Planetree International Development Limited increased its holding of OSHIDORI (00622) by approximately 760 million shares, at an average price of HK$0.494 per share.
On November 3, Planetree International Development Limited increased its holdings of Viva Biotech Holdings (00622) by 7.60250187 billion shares, at an average price of 0.494 Hong Kong dollars per share, with a total amount of approximately 3.76 billion Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on November 3, Planetree International Development Limited increased its holdings of OSHIDORI (00622) by 7.60250187 billion shares at an average price of HK$0.494 per share, with a total amount of approximately HK$376 million. After the increase, the latest number of shares held is approximately 1.079 billion shares, with a latest holding percentage of 17.45%.
Related Articles

Hangzhou Huning Elevator Parts (300669.SZ) plans to inject 40 million yuan into Hongjian Optoelectronics to advance strategic transformation and upgrading.

Wang Shan Wang Shui-B (02630) has a sale price of HK$33.37 per share. The Hong Kong public offering has been oversubscribed 6238.42 times.

US Stock Market Move | Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) surged nearly 13% in pre-market trading, with Q3 revenue and adjusted earnings per share both exceeding expectations.
Hangzhou Huning Elevator Parts (300669.SZ) plans to inject 40 million yuan into Hongjian Optoelectronics to advance strategic transformation and upgrading.

Wang Shan Wang Shui-B (02630) has a sale price of HK$33.37 per share. The Hong Kong public offering has been oversubscribed 6238.42 times.

US Stock Market Move | Teva Pharmaceutical Industries Limited Sponsored ADR (TEVA.US) surged nearly 13% in pre-market trading, with Q3 revenue and adjusted earnings per share both exceeding expectations.

RECOMMEND

Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025

Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025

Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025


